Family Medicine Doctors in Charleston, IL Accepting Medicare

12 Family Medicine doctors found. Showing 1 - 12

Joan V Alvarado, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 116 W Buchanan Ave, Charleston, IL 61920 Phone: 217-345-7700    Fax: 217-345-7200

Erica Davis Perrino, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 116 W Buchanan Ave, Charleston, IL 61920 Phone: 217-345-7700    Fax: 217-345-7200

Dr. Cornelius Edward Whalen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 925 18th St, Charleston, IL 61920 Phone: 217-345-2123    Fax: 217-345-3907

Mark Emenecker, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 116 W Buchanan Ave, Charleston, IL 61920 Phone: 217-345-7700    Fax: 217-345-7200

Dr. Jason B Jerabek, DO Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 506 W Lincoln Ave, Suite 200 A, Charleston, IL 61920 Phone: 217-281-0024    Fax: 217-345-7146

John B Hutchinson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 600 Lincoln Ave, Charleston, IL 61920 Phone: 217-581-7774

Dr. Renu Bajaj, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 W Lincoln Ave, Charleston, IL 61920 Phone: 217-345-3909    Fax: 217-345-3007

Dr. Joseph Wall, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 19416 E County Road 700n, Charleston, IL 61920 Phone: 217-348-1297

Dr. Todd E Garner, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 600 Lincoln Ave, Charleston, IL 61920 Phone: 217-581-3013    Fax: 217-581-3899

Dr. Sheila Denise Baker, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 600 Lincoln Ave, Eastern Illinois University, Charleston, IL 61920 Phone: 217-581-3015    Fax: 217-581-3899

Dr. Leland E. Mcneill, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 506 W Lincoln Ave, Suites 200 A And B, Charleston, IL 61920 Phone: 217-348-8727    Fax: 217-345-7146

Gary Mikel, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1310 Audrey Ln, Charleston, IL 61920 Phone: 999-999-9999

News Archive

Possible therapies to address cognitive symptoms in individuals with schizophrenia

By studying specially bred mice with specific developmental and cognitive traits resembling those seen in schizophrenia, UC San Francisco researchers have provided new evidence that abnormal rhythmic activity in particular brain cells contributes to problems with learning, attention, and decision-making in individuals with that disorder.

Prescription Solutions launches consumer website that features updated content and drug pricing tool

Prescription Solutions, a leading pharmacy benefits management organization and a UnitedHealth Group (NYSE: UNH) company, today announced the launch of its refreshed consumer website, www.PrescriptionSolutions.com, featuring enhanced functionality, updated content, and simplified navigation. The site makes prescription drug information more accessible and provides education customers need to make informed health care choices.

Australia's medicines regulator close to decision on herceptin

Australia's medicines regulator, the Therapeutic Goods Administration (TGA) is considering a recommendation by its expert committee, the Australian Drug Evaluation Committee (ADEC), to conditionally approve an application by Roche Products Pty Limited to extend the registration of the breast cancer drug Herceptin (trastuzumab) for use in HER2 positive localised breast cancer in addition to chemotherapy.

Researchers identify possible causes of colorectal cancer resistance to bevacizumab drug

A University of Colorado Cancer Center study published in the journal PLOS ONE shows that when colorectal cancer is targeted by the drug bevacizumab (Avastin), tumors may switch dependence from VEGF-A, which is targeted by the drug, to related growth factors in including VEGF-C, VEGF-D and placental growth factor.

Biopure submits IND for trial in patients with acute myeloid leukemia

Biopure Corporation has announced that it has submitted to the Food and Drug Administration (FDA) an investigational new drug (IND) application to conduct a pilot phase 2 clinical trial of the company's oxygen therapeutic Hemopure [hemoglobin glutamer - 250 (bovine)].

Read more Medical News

› Verified 6 days ago